> Here you have a ton of studies claiming to have found benefit Maybe the real reason we aren't seeing more trials being funded is that scientists are looking

> Here you have a ton of studies claiming to have found benefit Maybe the real reason we aren't seeing more trials being funded is that scientists are looking at these early studies and what we already know of the drug and concluding that it's not an avenue worth pursuing? (Especially when we already have several proven vaccines in place). By way of analogy are you going to invest your time to build a web framework for Cobol running on mainframes? I'm sure it's been done, but it's probably not worth your time to build one as we already have many high quality web frameworks available.